Provided by Tiger Trade Technology Pte. Ltd.

Nuvectis Pharma, Inc.

21.92
+1.205.79%
Post-market: 21.70-0.2200-1.00%19:30 EDT
Volume:207.52K
Turnover:4.50M
Market Cap:714.19M
PE:-16.80
High:22.00
Open:21.11
Low:21.04
Close:20.72
52wk High:29.28
52wk Low:5.55
Shares:32.58M
Float Shares:21.23M
Volume Ratio:1.16
T/O Rate:0.98%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.3045
EPS(LYR):-1.3236
ROE:-214.58%
ROA:-73.07%
PB:78.64
PE(LYR):-16.56

Loading ...

Nuvectis Pharma announces common stock offering, no amount given

TIPRANKS
·
Jun 30

Nuvectis Pharma Launches Underwritten Public Offering of Common Stock

Reuters
·
Jun 30

Nuvectis Pharma Announces Proposed Public Offering of Common Stock

THOMSON REUTERS
·
Jun 30

Nuvectis Pharma up over 32%, on Pace for Record High Close

Dow Jones
·
Jun 25

Analysts Offer Insights on Healthcare Companies: AdaptHealth (AHCO), Argenx Se (ARGX) and Nuvectis Pharma (NVCT)

TIPRANKS
·
Jun 24

Roth MKM Remains a Buy on Nuvectis Pharma (NVCT)

TIPRANKS
·
Jun 23

Nuvectis Pharma Jumps 20% To 52-Week High — Here's Why NVCT Stock Is Trending

Benzinga_recent_news
·
Jun 23

Haisco Pharmaceutical Group Enters Licensing Agreement with Nuvectis for Two Drug Candidates

Stock News
·
Jun 23

Nuvectis Pharma price target raised to $22 from $18 at Lucid Capital

TIPRANKS
·
Jun 23

Nuvectis Pharma Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Jun 22

Nuvectis Pharma price target raised to $39 from $13 at H.C. Wainwright

TIPRANKS
·
Jun 22

Nuvectis Lands Major Haisco Deal for Two Potentially Best-in-Class Compounds in Multi-Billion-Dollar Markets

TIPRANKS
·
Jun 22

Nuvectis Expands Pipeline With 2-Drug Licensing Deal From Haisco

MT Newswires Live
·
Jun 22

BUZZ-Nuvectis rises as it secures two experimental drugs in licensing deal

Reuters
·
Jun 22

Nuvectis Pharma announces license agreement with Haisco for two compounds

TIPRANKS
·
Jun 22

Nuvectis licenses ex-China rights to Haisco’s NXP100, NXP200 in deal worth up to USD 1.42 billion

Reuters
·
Jun 22

Nuvectis Pharma Inc: Haisco Also Retains Rights for Nxp100 in India and Certain Southeast Asia Territories

THOMSON REUTERS
·
Jun 22

Nuvectis: Haisco to Receive Upfront, Near-Term Payments up to $40 Mln, Eligible to Receive up to $1.421Bn in Additional Milestones, Tiered Royalties

THOMSON REUTERS
·
Jun 22

Nuvectis Pharma - Agreement Subject to Financing Conditions Requiring Nuvectis to Ensure Sufficient Capital

THOMSON REUTERS
·
Jun 22

Nuvectis Pharma - Expands Pipeline With Nxp100 and Nxp200 in-Licensing

THOMSON REUTERS
·
Jun 22